Announced last month, India’s 2014 budget for the country’s Ministry of Science and Technology is set to increase, including both plan and non-plan items (see IBO 8/31/09). Within the Ministry, the budget for the Department of Science and Technology would rise 24.9% to INR 3184.27 crore ($590.4 million). By budget line, the budget for Autonomous […]
A survey by Chemical & Engineering News (C&EN) finds that 10 chemical companies plan to increase their combined R&D spending 3.6% this year to $7.4 billion, following a 7.8% increase in 2012. Only one of the 10 firms plans to decrease R&D expenditures. Eighteen companies surveyed plan to increase expenditures for plants and equipment by […]
Biosimilar drugs are proving more difficult to produce than originally anticipated in some cases. Merck & Co., Samsung and Teva Pharmaceutical Industries are among the companies that have recently faced delays in the development of biosimilars. Reasons for the setbacks include complications in creating biologics, new patents on the original drugs or their manufacturing processes, […]
Fourth-quarter 2012 IBO Life Science Index sales grew 6.4%, 6.7% organically, to $3,791 million. Operating profit improved 1.7% to $844 million. Based on continuing operations, operating margin fell 100 basis points to 21.3% of sales. For 2012, Life Science Index sales expanded 4.0%, 4.2% organically, to $13,534 million. Operating profit grew 1.6% to $2,870 million. […]
On February 15, the US Department of Justice and the National Institute of Standards and Technology (NIST) announced plans for the National Commission on Forensic Science initiative, which will address quality issues regarding forensic evidence used in criminal cases. The Commission will develop proposals for the US attorney general and Department of Justice and will […]
Shenzhen, China, 3/15/13; Shenzhen, China, 3/12/13; Mountain View, CA, 3/12/13—BGI-Shenzhen’s wholly owned subsidiary Beta Acquisition Corporation has completed its all-cash tender offer for sequencing service provider Complete Genomics. BGI will purchase all outstanding shares of Complete Genomics common stock for $3.15 per share in cash without interest. Complete Genomics will become a wholly owned subsidiary […]
Milford, MA 3/14/13—Waters and GC company DANI Instruments have partnered to connect their chromatography products. Waters’ Empower Chromatography Data Software will work with DANI’s Headspace and Gas Chromatography Instruments. The software links an array of chromatographic modules to the Empower data management system. “The cooperation between DANI and Waters will provide Empower Software users with […]
Sydney, Australia 1/24/13; Palo Alto, CA 3/4/13—Bioinformatics firm PREMIER Biosoft has acquired the assets of the ProteoIQ MS software business from NuSep for an undisclosed amount. The ProteoIQ platform provides proteomic data analysis to streamline the process of statistical validation, protein quantification and comparative proteomics. “For the rapidly growing proteomics market, ProteoIQ is a strategic […]
New York, NY 3/7/13—At its annual investors meeting, Agilent Technologies announced that it will exit its OEM and Specialty magnets business. The business, which it had acquired when it bought Varian (see IBO 7/31/09), makes super high-end magnets for research and other applications. Nick Roelofs, president of Agilent’s Life Sciences Group, told the conference, “This […]
New York, NY 3/5/13; New York, NY 3/6/13; New York, NY 3/12/13—Reuters reported on March 5 that private equity firms are interested in jointly making an offer to acquire Life Technologies (see IBO 1/31/13, 2/28/13), according to people familiar with the situation. The consortium would include Blackstone, Carlyle, TPG Capital and Temasek Holdings, but discussions […]
Pay Invoice
Latest Blogs
-
LAUDA: Temperature Control Innovation
December 10, 2024 4:11 pm
-
Perseverance Forecasted for the Pharmaceutical Market for Analytical and Scientific Instrumentation
October 24, 2024 5:17 pm
-
M&A Activity in the Analytical Instrumentation and Lab Tools Market. 2021-2023
September 30, 2024 1:32 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
